The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Open accessAbstract
The c-Jun N-terminal kinases (JNKs), with its members JNK1, JNK2, and JNK3, is a subfamily of (MAPK) mitogen-activated protein kinases. JNK signaling regulates a wide range of cellular processes, including cell proliferation, differentiation, survival, apoptosis, and inflammation. Dysregulation of JNK pathway is associated with a wide range of immune disorders and cancer. Our objective is to provide a review of JNK proteins and their upstream regulators and downstream effector molecules in common skin disorders, including psoriasis, dermal fibrosis, scleroderma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012
Rogers, H. W., Weinstock, M. A., Feldman, S. R., & Coldiron, B. M. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.1187 · Cited by 1,815
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
AP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,736
MAP Kinases in the Immune Response
Dong, C., Davis, R. J., & Flavell, R. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091301.131133 · Cited by 1,662
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
Dhanasekaran, D. N., & Reddy, E. P. (2008) · Oncogene · doi:10.1038/onc.2008.301 · Cited by 1,525
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
Selective interaction of JNK protein kinase isoforms with transcription factors.
Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Dérijard, B., & Davis, R. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00636.x · Cited by 1,338
New insights into TGF-β/Smad signaling in tissue fibrosis
Hu, H.-H., Chen, D.-Q., Wang, Y.-N., Feng, Y.-L., Cao, G., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.008 · Cited by 1,179
Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
Kidd, P. M. (2003) · PubMed · Cited by 1,102
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., Bowman, E. P., & Krueger, J. G. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701213 · Cited by 1,082
Hori, S., Nomura, T., & Sakaguchi, S. (2017) · The Journal of Immunology · doi:10.1093/jimmunol/198.3.981 · Cited by 1,066
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055 · cited 2×
“The balance between Th1 and Th2 immune responses is crucial for normal tissue homeostasis [41]; this is known as the Th1 and Th2 paradigm.”
BackgroundIdentification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2467 · Cited by 1,024
Yamamoto, K., Ichijo, H., & Korsmeyer, S. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8469 · Cited by 1,003
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843
Basal cell carcinomas: attack of the hedgehog
Epstein, E. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2503 · Cited by 834
The 3 major types of innate and adaptive cell-mediated effector immunity
Annunziato, F., Romagnani, C., & Romagnani, S. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.001 · Cited by 818
Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in Mammals
Morrison, D. K., & Davis, R. J. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111401.091942 · Cited by 786
The role of the Hedgehog signaling pathway in cancer: A comprehensive review
Skoda, A. M., Simovic, D., Karin, V., Kardum, V., Vranic, S., & Serman, L. (2018) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2018.2756 · Cited by 781
Rubin, A. I., Chen, E. H., & Ratner, D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044151 · Cited by 769
Immunological decision‐making: how does the immune system decide to mount a helper T‐cell response?
Kaiko, G. E., Horvat, J. C., Beagley, K. W., & Hansbro, P. M. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02719.x · Cited by 658
JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation
Han, M. S., Jung, D. Y., Morel, C., Lakhani, S. A., Kim, J. K., Flavell, R. A., & Davis, R. J. (2013) · Science · doi:10.1126/science.1227568 · Cited by 636
Secretion of Wnt Ligands Requires Evi, a Conserved Transmembrane Protein
Bartscherer, K., Pelte, N., Ingelfinger, D., & Boutros, M. (2006) · Cell · doi:10.1016/j.cell.2006.04.009 · Cited by 580
Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases
Bogoyevitch, M. A., & Kobe, B. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00025-06 · Cited by 573
Niyonsaba, F., Ushio, H., Nakano, N., Ng, W., Sayama, K., Hashimoto, K., Nagaoka, I., Okumura, K., & Ogawa, H. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700599 · Cited by 544
JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships
Zeke, A., Misheva, M., Reményi, A., & Bogoyevitch, M. A. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00043-14 · Cited by 523
Seki, E., Brenner, D. A., & Karin, M. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.004 · Cited by 487
The American Cancer Society’s Facts & Figures: 2020 Edition
Hallquist Viale, R. (2020) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2020.11.2.1 · Cited by 484
AP-1 — The Jun proteins: Oncogenes or tumor suppressors in disguise?
Shaulian, E. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.008 · Cited by 425
PSORS2 Is Due to Mutations in CARD14
Jordan, C. T., Cao, L., Roberson, E. D. O., Pierson, K. C., Yang, C.-F., Joyce, C. E., Ryan, C., Duan, S., Helms, C. A., Liu, Y., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.012 · Cited by 416
Self-citationc-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
Yarza, R., Vela, S., Solas, M., & Ramirez, M. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00321 · Cited by 410
Bakiri, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.2056 · Cited by 398
Regulation of JNK and p38 MAPK in the immune system: Signal integration, propagation and termination
Huang, G., Shi, L. Z., & Chi, H. (2009) · Cytokine · doi:10.1016/j.cyto.2009.08.002 · Cited by 368
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Fedorov, O., Marsden, B., Pogacic, V., Rellos, P., Müller, S., Bullock, A. N., Schwaller, J., Sundström, M., & Knapp, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708800104 · Cited by 359
Chakraborty, D., Šumová, B., Mallano, T., Chen, C.-W., Distler, A., Bergmann, C., Ludolph, I., Horch, R. E., Gelse, K., Ramming, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01236-6 · Cited by 356
Emerging roles of ATF2 and the dynamic AP1 network in cancer
Lopez-Bergami, P., Lau, E., & Ronai, Z. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2681 · Cited by 350
JNK signalling in cancer: in need of new, smarter therapeutic targets
Bubici, C., & Papa, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12432 · Cited by 346
c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges
Bogoyevitch, M. A., Ngoei, K. R. W., Zhao, T. T., Yeap, Y. Y. C., & Ng, D. C. H. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.002 · Cited by 323
JNK signaling in cancer cell survival
Wu, Q., Wu, W., Fu, B., Shi, L., Wang, X., & Kuca, K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21574 · Cited by 322
Scanning the Immunopathogenesis of Psoriasis
Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G., & Romanelli, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010179 · Cited by 320
Theoharides, T. C., Zhang, B., Kempuraj, D., Tagen, M., Vasiadi, M., Angelidou, A., Alysandratos, K.-D., Kalogeromitros, D., Asadi, S., Stavrianeas, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000803107 · Cited by 318
Di Meglio, P., Villanova, F., & Nestle, F. O. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015354 · Cited by 317
Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Muzic, J. G., Schmitt, A. R., Wright, A. C., Alniemi, D. T., Zubair, A. S., Olazagasti Lourido, J. M., Sosa Seda, I. M., Weaver, A. L., & Baum, C. L. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.02.015 · Cited by 301
The functional contrariety of JNK
Bode, A. M., & Dong, Z. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20348 · Cited by 293
Rewired ERK-JNK Signaling Pathways in Melanoma
Lopez-Bergami, P., Huang, C., Goydos, J. S., Yip, D., Bar-Eli, M., Herlyn, M., Smalley, K. S. M., Mahale, A., Eroshkin, A., Aaronson, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.009 · Cited by 286
The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs)
Barr, R. K., & Bogoyevitch, M. A. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00093-0 · Cited by 284
Analysis of FOXP3 Reveals Multiple Domains Required for Its Function as a Transcriptional Repressor
Lopes, J. E., Torgerson, T. R., Schubert, L. A., Anover, S. D., Ocheltree, E. L., Ochs, H. D., & Ziegler, S. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3133 · Cited by 273
Regulation of the immune response by stress‐activated protein kinases
Rincón, M., & Davis, R. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00744.x · Cited by 266
Wong, C. H., Iskandar, K. B., Yadav, S. K., Hirpara, J. L., Loh, T., & Pervaiz, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009996 · Cited by 263
JunD Mediates Survival Signaling by the JNK Signal Transduction Pathway
Lamb, J. A., Ventura, J.-J., Hess, P., Flavell, R. A., & Davis, R. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00203-x · Cited by 262
Hijacking of the AP-1 Signaling Pathway during Development of ATL
Gazon, H., Barbeau, B., Mesnard, J.-M., & Peloponese, J.-M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02686 · Cited by 250
Cortez, D. M., Feldman, M. D., Mummidi, S., Valente, A. J., Steffensen, B., Vincenti, M., Barnes, J. L., & Chandrasekar, B. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00928.2007 · Cited by 241
Kim, B. E., Howell, M. D., Guttman, E., Gilleaudeau, P. M., Cardinale, I. R., Boguniewicz, M., Krueger, J. G., & Leung, D. Y. M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.24 · Cited by 239
PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics
Ying, H.-Z., Chen, Q., Zhang, W.-Y., Zhang, H.-H., Ma, Y., Zhang, S.-Z., Fang, J., & Yu, C.-H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7641 · Cited by 238
Klinkhammer, B. M., Floege, J., & Boor, P. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.11.008 · Cited by 229
Riesenberg, S., Groetchen, A., Siddaway, R., Bald, T., Reinhardt, J., Smorra, D., Kohlmeyer, J., Renn, M., Phung, B., Aymans, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms9755 · Cited by 227
The JNK Signaling Pathway in Renal Fibrosis
Grynberg, K., Ma, F. Y., & Nikolic-Paterson, D. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00829 · Cited by 223
Schnidar, H., Eberl, M., Klingler, S., Mangelberger, D., Kasper, M., Hauser-Kronberger, C., Regl, G., Kroismayr, R., Moriggl, R., Sibilia, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2331 · Cited by 212
Identification of the Critical Features of a Small Peptide Inhibitor of JNK Activity
Barr, R. K., Kendrick, T. S., & Bogoyevitch, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107565200 · Cited by 211
JNK pathway: diseases and therapeutic potential
CUI, J., ZHANG, M., ZHANG, Y.-Q., & XU, Z.-H. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00579.x · Cited by 201
JNK Pathway Signaling: A Novel and Smarter Therapeutic Target for Various Biological Diseases
Kumar, A., Singh, U. K., Kini, S. G., Garg, V., Agrawal, S., Tomar, P. K., Pathak, P., Chaudhary, A., Gupta, P., & Malik, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.132 · Cited by 200
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Gilbane, A. J., Denton, C. P., & Holmes, A. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4230 · Cited by 196
NF-κB signaling pathways regulated by CARMA family of scaffold proteins
Blonska, M., & Lin, X. (2011) · Cell Research · doi:10.1038/cr.2010.182 · Cited by 192
The c-Jun N-terminal kinase pathway and apoptotic signaling (review).
Chen, Y. R., & Tan, T. H. (2000) · International Journal of Oncology · doi:10.3892/ijo.16.4.651 · Cited by 191
Non-canonical (non-SMAD2/3) TGF-β signaling in fibrosis: Mechanisms and targets
Finnson, K. W., Almadani, Y., & Philip, A. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.11.013 · Cited by 179
She, Q., Chen, N., Bode, A. M., Flavell, R. A., & Dong, Z. (2002) · PubMed · Cited by 173
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Lu, H., Liu, S., Zhang, G., Wu, B., Zhu, Y., Frederick, D. T., Hu, Y., Zhong, W., Randell, S., Sadek, N., et al. (2017) · Nature · doi:10.1038/nature24040 · Cited by 169
Self-citationKannan, N., & Neuwald, A. F. (2004) · Protein Science · doi:10.1110/ps.04637904 · Cited by 167
Regulation of Drosophila lifespan by JNK signaling
Biteau, B., Karpac, J., Hwangbo, D., & Jasper, H. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.003 · Cited by 166
Physiological roles of MKK4 and MKK7: Insights from animal models
Wang, X., Destrument, A., & Tournier, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.016 · Cited by 165
AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma
Kappelmann, M., Bosserhoff, A., & Kuphal, S. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.003 · Cited by 162
Wang, W., Shi, L., Xie, Y., Ma, C., Li, W., Su, X., Huang, S., Chen, R., Zhu, Z., Mao, Z., et al. (2004) · Neuroscience Research · doi:10.1016/j.neures.2003.10.012 · Cited by 160
Role of the JNK Pathway in Human Diseases
Sabapathy, K. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00013-4 · Cited by 159
Szczepankiewicz, B. G., Kosogof, C., Nelson, L. T. J., Liu, G., Liu, B., Zhao, H., Serby, M. D., Xin, Z., Liu, M., Gum, R. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060199b · Cited by 159
MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence
Wada, T., Joza, N. A., Cheng, H. M., Sasaki, T., Kozieradzki, I., Bachmaier, K., Katada, T., Schreiber, M. J., Wagner, E. F., Nishina, H., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1098 · Cited by 152
Ferrandi, C., Ballerio, R., Gaillard, P., Giachetti, C., Carboni, S., Vitte, P., Gotteland, J., & Cirillo, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705873 · Cited by 148
Ostrowski, S. M., Belkadi, A., Loyd, C. M., Diaconu, D., & Ward, N. L. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.60 · Cited by 147
Ramsdale, R., Jorissen, R. N., Li, F. Z., Al-Obaidi, S., Ward, T., Sheppard, K. E., Bukczynska, P. E., Young, R. J., Boyle, S. E., Shackleton, M., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aab1111 · Cited by 143
Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy
Smola, S. (2017) · Viruses · doi:10.3390/v9090254 · Cited by 143
Wounding enhances epidermal tumorigenesis by recruiting hair follicle keratinocytes
Kasper, M., Jaks, V., Are, A., Bergström, Å., Füllgrabe, A., Svärd, J., Teglund, S., Barker, N., & Toftgård, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014489108 · Cited by 142
JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers
van der Velden, J. L. J., Ye, Y., Nolin, J. D., Hoffman, S. M., Chapman, D. G., Lahue, K. G., Abdalla, S. T., Chen, P., Liu, Y., Bennett, B. L., et al. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0117-2 · Cited by 134
Self-citationGaillard, P., Jeanclaude-Etter, I., Ardissone, V., Arkinstall, S., Cambet, Y., Camps, M., Chabert, C., Church, D. J., Cirillo, R., Gretener, D., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0310986 · Cited by 129
Wounding mobilizes hair follicle stem cells to form tumors
Wong, S. Y., & Reiter, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013098108 · Cited by 124
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
Krenitsky, V. P., Nadolny, L., Delgado, M., Ayala, L., Clareen, S. S., Hilgraf, R., Albers, R., Hegde, S. G., D’Sidocky, N., Sapienza, J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.027 · Cited by 121
Epigenetic Activation of AP1 Promotes Squamous Cell Carcinoma Metastasis
Ding, X., Pan, H., Li, J., Zhong, Q., Chen, X., Dry, S., & Wang, C. (2013) · Science Signaling · doi:10.1126/scisignal.2003884 · Cited by 120
Coquet, J. M., Middendorp, S., Horst, G., Kind, J., Veraar, E. A. M., Xiao, Y., Jacobs, H., & Borst, J. G. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.009 · Cited by 119
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Beyer, C., Reichert, H., Akan, H., Mallano, T., Schramm, A., Dees, C., Palumbo‐Zerr, K., Lin, N., Distler, A., Gelse, K., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202544 · Cited by 117
Calcitonin gene‐related peptide: key regulator of cutaneous immunity
Granstein, R. D., Wagner, J. A., Stohl, L. L., & Ding, W. (2014) · Acta Physiologica · doi:10.1111/apha.12442 · Cited by 107
Brembilla, N. C., Montanari, E., Truchetet, M., Raschi, E., Meroni, P. L., & Chizzolini, C. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4334 · Cited by 101
Avouac, J., Palumbo, K., Tomčík, M., Zerr, P., Dees, C., Horn, A., Maurer, B., Akhmetshina, A., Beyer, C., Sadowski, A., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33501 · Cited by 100
Fallahi‐Sichani, M., Moerke, N. J., Niepel, M., Zhang, T., Gray, N. S., & Sorger, P. K. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145877 · Cited by 99
Expression of activator protein-1 (AP-1) family members in breast cancer
Razavirad, A., Gao, H., Ghiasvand, R., Zhao, C., Zendehdel, K., & Dahlman‐Wright, K. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-441 · Cited by 99
Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients
Gao, L., Li, K., Li, F., Li, H., Liu, L., Wang, L., Zhang, Z., Gao, T., & Liu, Y. (2009) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2009.09.010 · Cited by 99
Self-citationRegulation of p73-mediated apoptosis by c-Jun N-terminal kinase
Jones, E. V., Dickman, M. J., & Whitmarsh, A. J. (2007) · Biochemical Journal · doi:10.1042/bj20061778 · Cited by 95
Constitutive Aberrant Endogenous Interleukin-1 Facilitates Inflammation and Growth in Human Melanoma
Qin, Y. W., Ekmekçioglu, S., Liu, P., Duncan, L. M., Lizee, G. A., Poindexter, N. J., & Grimm, E. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0279 · Cited by 94
Jin, Y., Park, I., Hong, I., Byun, H.-J., Choi, J., Kim, Y., & Lee, H. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.08.012 · Cited by 91
Sonic Hedgehog Induces Epidermal Growth Factor Dependent Matrix Infiltration in HaCaT Keratinocytes
Bigelow, R. L. H., Jen, E. Y., Delehedde, M., Chari, N. S., & McDonnell, T. J. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23590.x · Cited by 91
Grabiec, A. M., Angiolilli, C., Hartkamp, L. M., van Baarsen, L. G. M., Tak, P. P., & Reedquist, K. A. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203610 · Cited by 84
Genomic alterations driving psoriasis pathogenesis
Singh, S., Pradhan, D., Puri, P., Ramesh, V., Aggarwal, S., Nayek, A., & Jain, A. K. (2018) · Gene · doi:10.1016/j.gene.2018.09.042 · Cited by 84
Fineschi, S., Goffin, L., Rezzonico, R., Cozzi, F., Dayer, J., Meroni, P. L., & Chizzolini, C. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24049 · Cited by 83
Kukekov, N. V., Xu, Z., & Greene, L. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601056200 · Cited by 83
MMP-1 polymorphism and its relationship to pathological processes
Arakaki, P. A., Marques, M. R., & dos Santos, M. C. L. G. (2009) · Journal of Biosciences · doi:10.1007/s12038-009-0035-1 · Cited by 80
Katagiri, C., Nakanishi, J., Kadoya, K., & Hibino, T. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508064 · Cited by 80
Role for WNT16B in human epidermal keratinocyte proliferation and differentiation
Teh, M., Blaydon, D. C., Ghali, L. R., Edmunds, S., Pantazi, E., Barnes, M. R., Leigh, I. M., Kelsell, D. P., & Philpott, M. P. (2007) · Journal of Cell Science · doi:10.1242/jcs.03329 · Cited by 78
Zhang, P., Cai, Y., Soofi, A. A., & Dressler, G. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357202 · Cited by 76
The paracaspase MALT1 mediates CARD14‐induced signaling in keratinocytes
Afonina, I. S., Nuffel, E. V., Baudelet, G., Driege, Y., Kreike, M., Staal, J., & Beyaert, R. (2016) · EMBO Reports · doi:10.15252/embr.201642109 · Cited by 76
Connexin Levels Regulate Keratinocyte Differentiation in the Epidermis
Langlois, S., Maher, A. C., Manias, J. L., Shao, Q., Kidder, G. M., & Laird, D. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703623200 · Cited by 75
Poulalhon, N., Farge, D., Roos, N., Tacheau, C., Neuzillet, C., Michel, L., Mauviel, A., & Verrecchia, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606366200 · Cited by 75
Plasma concentration of selected neuropeptides in patients suffering from psoriasis
Reich, A., Orda, A., Wiśnicka, B., & Szepietowski, J. C. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00544.x · Cited by 75
Loesche, M. A., Farahi, K., Capone, K. A., Fakharzadeh, S. S., Blauvelt, A., Duffin, K. C., DePrimo, S. E., Muñoz‐Elías, E. J., Brodmerkel, C. M., Dasgupta, B., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.1501 · Cited by 75
YAP‐TEAD signaling promotes basal cell carcinoma development via a c‐JUN/AP1 axis
Maglic, D., Schlegelmilch, K., Dost, A. F. M., Panero, R., Dill, M. T., Calogero, R., & Camargo, F. D. (2018) · The EMBO Journal · doi:10.15252/embj.201798642 · Cited by 75
Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells
Kanda, N., Kamata, M., Tada, Y., Ishikawa, T., Sato, S., & Watanabe, S. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0111004 · Cited by 71
Scaffold Proteins in Mammalian MAP Kinase Cascades
Yoshioka, K. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh079 · Cited by 70
Kamenecka, T., Jiang, R., Song, X., Duckett, D. R., Chen, W., Ling, Y. Y., Habel, J. E., Laughlin, J. D., Chambers, J. W., Figuera-Losada, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901351f · Cited by 69
PSORS1: Linking Genetics and Immunology
Elder, J. T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700357 · Cited by 68
Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease
Tourkina, E., Richard, M., Oates, J. C., Hofbauer, A. F., Bonner, M., Göőz, P., Visconti, R. P., Zhang, J., Znoyko, S. L., Hatfield, C. M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117580 · Cited by 66
Self-citationJNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis
Alexaki, V. I., Javelaud, D., & Mauviel, A. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00466.x · Cited by 65
Reich, N., Tomčík, M., Zerr, P., Lang, V. R., Dees, C., Avouac, J., Palumbo, K., Horn, A., Akhmetshina, A., Beyer, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200412 · Cited by 64
Fineschi, S., Reith, W., Guerne, P. A., Dayer, J., & Chizzolini, C. (2006) · The FASEB Journal · doi:10.1096/fj.05-4870fje · Cited by 63
Barr, R. K., Boehm, I., Attwood, P. V., Watt, P. M., & Bogoyevitch, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402181200 · Cited by 62
Molecular signaling cascades involved in nonmelanoma skin carcinogenesis
Feehan, R. P., & Shantz, L. M. (2016) · Biochemical Journal · doi:10.1042/bcj20160471 · Cited by 62
Ke, H., Augustine, C. K., Gandham, V. D., Jin, J. Y., Tyler, D. S., Akiyama, S. K., Hall, R. P., & Zhang, J. Y. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.253 · Cited by 61
Self-citationIdentification of small-molecule inhibitors of the JIP–JNK interaction
Chen, T. X., Kablaoui, N. M., Little, J., Timofeevski, S. L., Tschantz, W. R., Chen, P., Feng, J., Charlton, M. E., Stanton, R. V., & Bauer, P. H. (2009) · Biochemical Journal · doi:10.1042/bj20081899 · Cited by 57
The c-Jun NH2-Terminal Kinase 2 Plays a Dominant Role in Human Epidermal Neoplasia
Ke, H., Harris, R., Coloff, J. L., Jin, J. Y., Leshin, B., de Marval, P. L. M., Tao, S., Rathmell, J. C., Hall, R. P., & Zhang, J. Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2923 · Cited by 55
Self-citationCooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes
Laner‐Plamberger, S., Kaser-Eichberger, A., Paulischta, M., Hauser‐Kronberger, C., Eichberger, T., & Frischauf, A. (2009) · Oncogene · doi:10.1038/onc.2009.10 · Cited by 54
Zhang, X., WU, J. M., Luo, S., Lechler, T., & Zhang, J. Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9110 · Cited by 51
Self-citationSurgical management of non melanoma skin cancer of the head and neck
Kansara, S. G., Bell, D., & Weber, R. S. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104485 · Cited by 50
Carboni, S., Boschert, U., Gaillard, P., Gotteland, J., Gillon, J., & Vitte, P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707574 · Cited by 49
Wu, P., Ma, G., Zhu, X., Gu, T., Zhang, J., Sun, Y., Xu, H., Huo, R., Wang, B., Shen, B., et al. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.11.003 · Cited by 49
Self-citationC-Jun drives melanoma progression in PTEN wild type melanoma cells
Kappelmann‐Fenzl, M., Gebhard, C., Matthies, A. O., Kuphal, S., Rehli, M., & Bosserhoff, A. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1821-9 · Cited by 49
The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer.
Zhang, J. Y., & Selim, M. A. (2012) · PubMed · Cited by 48
Self-citationChen, P., O’Neal, J. F., Ebelt, N. D., Cantrell, M. A., Mitra, S., Nasrazadani, A., Vandenbroek, T. L., Heasley, L. E., & Berg, C. L. V. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010443 · Cited by 47
Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human Neoplasia
Zhang, J. Y., Adams, A. E., Ridky, T. W., Tao, S., & Khavari, P. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4017 · Cited by 47
Self-citationKusumaningrum, N., Lee, D. H., Yoon, H., Kim, Y. K., Park, C., & Chung, J. H. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.01.015 · Cited by 47
Th1/Th2 paradigm: not seeing the forest for the trees?
van Oosterhout, A. J. M., & Motta, A. C. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00014105 · Cited by 46
Kyula, J., Khan, A., Mansfield, D., Karapanagiotou, E. M., McLaughlin, M., Roulstone, V., Zaidi, S. H. H., Pencavel, T. D., Touchefeu, Y., Seth, R., et al. (2013) · Oncogene · doi:10.1038/onc.2013.112 · Cited by 45
CYLD Inhibits Tumorigenesis and Metastasis by Blocking JNK/AP1 Signaling at Multiple Levels
de Marval, P. L. M., Lutfeali, S., Jin, J. Y., Leshin, B., Selim, M. A., & Zhang, J. Y. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0360 · Cited by 45
Self-citationShi, Z., Tan, G., Cao, C.-X., Han, Y., Meng, Z., Man, X., Jiang, Z.-X., Zhang, Y.-P., Dang, N., Wei, K., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.11.002 · Cited by 45
Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK
Wolf, E. R., McAtarsney, C. P., Bredhold, K. E., Kline, A. M., & Mayo, L. D. (2018) · Science Signaling · doi:10.1126/scisignal.aao4170 · Cited by 45
The role of neuropeptides in the control of regional immunity
Lotti, T., D’Erme, A. M., & Hercogova, J. T. (2014) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2014.04.011 · Cited by 43
Arasa, J., Terencio, M. C., Ejarque, R. A., Marín-Castejón, A., Valcuende, F., Payá, M., & Montesinos, M. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00536 · Cited by 43
c-Jun Promotes whereas JunB Inhibits Epidermal Neoplasia
Jin, J. Y., Ke, H., Hall, R. P., & Zhang, J. Y. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.1 · Cited by 41
Self-citationThe Mitogen-Activated Protein Kinase Kinase 4 Has a Pro-Oncogenic Role in Skin Cancer
Finegan, K. G., & Tournier, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3669 · Cited by 41
Jørgensen, K., Davidson, B., & Flørenes, V. A. (2006) · Modern Pathology · doi:10.1038/modpathol.3800662 · Cited by 40
Li, H., Li, H., Huo, R., Wu, P., Shen, Z., Xu, H., Shen, B., & Li, N. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.05.018 · Cited by 40
Inhibitors of c-jun-N-Terminal Kinase (JNK)
LoGrasso, P. V., & Kamenecka, T. M. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708784912120 · Cited by 40
Cell Cycle Regulation of c-Jun N-Terminal Kinase Activity at the Centrosomes
MacCorkle, R. A., VanHooser, A., Goodrich, D. W., Brinkley, B. R., & Tan, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5948 · Cited by 38
Okada, M., Takeda, H., Sakaki, H., Kuramoto, K., Suzuki, S., Sanomachi, T., Togashi, K., Seino, S., & Kitanaka, C. (2017) · Oncotarget · doi:10.18632/oncotarget.22033 · Cited by 38
Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo
Kaoud, T. S., Johnson, W. H., Ebelt, N. D., Piserchio, A., Zamora‐Olivares, D., Ravenstein, S. X. V., Pridgen, J. R., Edupuganti, R., Sammons, R. M., Cano, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12996-8 · Cited by 37
Yu, X., Li, C., Xu, Y., et al. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.07.003 · Cited by 35
Wilhelm, M., Kukekov, N. V., Schmit, T. L., BIAGAS, K. V., Sproul, A. A., Gire, S., Maes, M. E., Xu, Z., & Greene, L. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269431 · Cited by 35
Bacteriophage of the Skin Microbiome in Patients with Psoriasis and Healthy Family Controls
Wang, H., Chan, H. H. L., Ni, M. Y., Lam, W., Chan, W. M. M., & Pang, H. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.05.023 · Cited by 35
Murai, M., Yamamura, K., Hashimoto‐Hachiya, A., Tsuji, G., Furue, M., & Mitoma, C. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.04.010 · Cited by 33
van der Velden, J. L., Alcorn, J. F., Chapman, D. G., Lundblad, L. K. A., Irvin, C. G., Davis, R. J., Butnor, K., & Janssen-Heininger, Y. M. W. (2020) · PLOS ONE · doi:10.1371/journal.pone.0226904 · Cited by 32
MALT1 promotes melanoma progression through JNK/c-Jun signaling
Wang, Y., Zhang, G.-H., Jin, J. Y., Degan, S., Tameze, Y., & Zhang, J. Y. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.68 · Cited by 32
Self-citationGong, X.-F., Wang, M., Tashiro, S., Onodera, S., & Ikejima, T. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.50 · Cited by 31
MALT1 is not alone after all: identification of novel paracaspases
Hulpiau, P., Driege, Y., Staal, J., & Beyaert, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2041-9 · Cited by 31
Kotb, I., Lewis, B. J., Barker, R. N., & Ormerod, A. D. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16336 · Cited by 31
Bourlidou, E., Vahtsevanos, K., Kyrgidis, Α., Tilaveridis, I., Patsatsi, A., Andreadis, D., Cheva, A., Patrikidou, A., Kitikidou, K., & Boboridis, K. G. (2019) · European Journal of Dermatology · doi:10.1684/ejd.2019.3643 · Cited by 29
Distler, A., Ziemer, C., Beyer, C., Lin, N., Chen, C., Palumbo‐Zerr, K., Dees, C., Weidemann, A., Distler, O., Schett, G. A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203995 · Cited by 28
Hu, L., Zhang, T., Liu, D., Guan, G., Huang, J., Proksch, P., Chen, X., & Lin, W. (2019) · RSC Advances · doi:10.1039/c9ra03640g · Cited by 28
Scaffold Protein JLP Is Critical for CD40 Signaling in B Lymphocytes
Wang, H., Yan, Q., Yang, T., Cheng, H., Du, J., Yoshioka, K., Kung, S. K. P., & Ding, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618496 · Cited by 24
Yu, X., Ren, X., Xu, Y.-H., Chen, L., Zhou, C.-L., & Li, C. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.05.002 · Cited by 23
Karakawa, M., Komine, M., Hanakawa, Y., Tsuda, H., Sayama, K., Tamaki, K., & Ohtsuki, M. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24643 · Cited by 22
Chen, L., Wu, J., Ren, W., Yang, X., & Shen, Z. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.10.018 · Cited by 20
Regulation of MHC Class I Expression by Foxp3 and Its Effect on Regulatory T Cell Function
Mu, J., Tai, X., Iyer, S. S., Weissman, J. D., Singer, A., & Singer, D. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302847 · Cited by 19
Retinoic acid for treatment of systemic sclerosis and morphea: A literature review
Thomas, R. M., Worswick, S., & Aleshin, M. A. (2016) · Dermatologic Therapy · doi:10.1111/dth.12455 · Cited by 19
JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells
Du, L., Anderson, A., Nguyen, K. T., Ojeda, S. S., Ortiz-Rivera, I., Nguyen, T., Zhang, T., Kaoud, T. S., Gray, N. S., Dalby, K. N., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00083 · Cited by 19
The Good, the Bad, and the Ugly of Sunscreens
Berwick, M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.227 · Cited by 16
Gow, W. R., Campbell, K., Meade, A. J., Watt, P. M., Milech, N., Knuckey, N. W., & Meloni, B. P. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.140 · Cited by 14
Shebzukhov, Y. V., Stanislawiak, S., Bezhaeva, T., Nedospasov, S. A., & Kuprash, D. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-02553-y · Cited by 14
POSH Regulates CD4+ T Cell Differentiation and Survival
Cunningham, C. A., Cardwell, L. N., Guan, Y., Teixeiro, E., & Daniëls, M. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501728 · Cited by 9
Inflammatory IL‐1β‐driven JNK activation in stage III melanoma
Qin, Y. W., Milton, D. R., Oba, J., Ding, Z., Lizee, G. A., Ekmekçioglu, S., & Grimm, E. A. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12348 · Cited by 7
Suppression of c-FLIPL promotes JNK activation in malignant melanoma cells
Tian, F., Hu, Y., Sun, X., Lu, G., Li, Y., Yang, J. X., & Tao, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4856 · Cited by 5
Cited by
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 427
Glutaminases regulate glutathione and oxidative stress in cancer
Matés, J. M., Campos-Sandoval, J. A., de los Santos-Jiménez, J., & Márquez, J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02838-8 · Cited by 91
Increase in primary cilia in the epidermis of patients with atopic dermatitis and psoriasis
Rizaldy, D., Toriyama, M., Kato, H., Fukui, R., Fujita, F., Nakamura, M., Okada, F., Morita, A., & Ishii, K. J. (2021) · Experimental Dermatology · doi:10.1111/exd.14285 · Cited by 17
Metadata
- Authors
- Hammouda, M., Ford, A., Liu, Y., & Zhang, J.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-04-02
- Volume
- 9
- Issue
- 4
- Pages
- 857
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3014808271
- Cited by
- 284
- References
- 184
- FWCI
- 9.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.